open access
Peripartum cardiomyopathy — case report
open access
Abstract
Abstract
Keywords
Peripartum cardiomiopathy; acute circulatory failure; levosimendan
About this articleTitle
Peripartum cardiomyopathy — case report
Journal
Issue
Pages
489-492
Published online
2017-11-22
DOI
10.5603/FC.2017.0092
Bibliographic record
Folia Cardiologica 2017;12(5):489-492.
Keywords
Peripartum cardiomiopathy
acute circulatory failure
levosimendan
Authors
Anna Maria Bednarek
Marcin Wita
Maciej Wybraniec
Katarzyna Mizia-Stec
References (6)- Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005; 111(16): 2050–2055.
- Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29(2): 270–276.
- Desplantie O, Tremblay-Gravel M, Avram R, et al. BRO-HF Initiative Investigators. The medical treatment of new-onset peripartum cardiomyopathy: a systematic review of prospective studies. Can J Cardiol. 2015; 31(12): 1421–1426.
- Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016; 18(9): 1096–1105.
- Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971; 44(6): 1053–1061.
- Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol. 2011; 100(7): 571–577.